Key Takeaways
- • Endeavor Catalyst has deployed $104.3 million in direct investments across Europe as of Q2 2026, a 19-fold increase from $5.4 million a decade ago, signaling a major strategic pivot toward the region.
- • The fund's European portfolio of 84 companies (20% of global portfolio) raised more than $8.3 billion across 2025 and H1 2026, with Endeavor Catalyst participating in over $3.2 billion of that capital.
- • Endeavor Catalyst made 13 new European investments in the first half of 2026 alone, following 14 new investments in 2025 and 7 in 2024, demonstrating accelerating deal flow in the region.
- • The European portfolio now includes 15 unicorn-valued companies, with several having completed IPOs or holding IPO potential, including Bending Spoons (NASDAQ: BSP), ElevenLabs, ICEYE, and Fever.
- • Europe's allocation within Endeavor Catalyst's fund vintages has grown substantially, rising from 11% of capital in Fund I to 25% by Fund IV, reflecting the region's increasing importance to the global venture strategy.
Summary
Endeavor Catalyst, the venture capital arm of the global Endeavor entrepreneur network, is significantly increasing its commitment to European startups and scale-ups. As of the second quarter of 2026, the fund has directly invested $104.3 million across Europe—a dramatic 19-fold increase from just $5.4 million invested a decade prior. This expansion reflects a strategic reorientation toward markets outside Silicon Valley and China, where Endeavor Catalyst now operates across 35+ markets globally.
The fund's European portfolio raised exceptional capital during 2025 and the first half of 2026. Companies backed by Endeavor Catalyst in Europe secured more than $8.3 billion in total funding across this period—over 6 times the combined total raised in 2023 and 2024. Of this amount, $3.2 billion came in rounds with direct Endeavor Catalyst participation, while an additional $5.1 billion was raised through independent rounds without the fund's direct involvement. This capital attraction underscores the maturation and market relevance of the fund's European investee companies.
The fund's portfolio expansion has been consistent and accelerating. Endeavor Catalyst now backs 84 companies across Europe, representing 20% of its global company portfolio spread across 10 country markets. During 2025, the fund made 14 new European investments, followed by 7 new investments in 2024 and 13 more in the first half of 2026. The portfolio has produced substantial outcomes: 15 European-founded companies have reached unicorn valuations ($1 billion or more), with several achieving liquidity events including Bending Spoons' NASDAQ listing under ticker BSP, alongside companies like ElevenLabs, ICEYE, and Fever that hold near-term IPO potential.
Europe's growing importance is evident in the fund's capital allocation across vintages. The region's share of capital deployed has expanded significantly from 11% in Fund I to 25% by Fund IV, demonstrating that European opportunity sourcing and deal quality have become core to Endeavor Catalyst's investment thesis. The fund's focus areas in Europe span fintech, e-commerce, MedTech, HealthTech, B2B services, and artificial intelligence.
The fund's European portfolio raised exceptional capital during 2025 and the first half of 2026. Companies backed by Endeavor Catalyst in Europe secured more than $8.3 billion in total funding across this period—over 6 times the combined total raised in 2023 and 2024. Of this amount, $3.2 billion came in rounds with direct Endeavor Catalyst participation, while an additional $5.1 billion was raised through independent rounds without the fund's direct involvement. This capital attraction underscores the maturation and market relevance of the fund's European investee companies.
The fund's portfolio expansion has been consistent and accelerating. Endeavor Catalyst now backs 84 companies across Europe, representing 20% of its global company portfolio spread across 10 country markets. During 2025, the fund made 14 new European investments, followed by 7 new investments in 2024 and 13 more in the first half of 2026. The portfolio has produced substantial outcomes: 15 European-founded companies have reached unicorn valuations ($1 billion or more), with several achieving liquidity events including Bending Spoons' NASDAQ listing under ticker BSP, alongside companies like ElevenLabs, ICEYE, and Fever that hold near-term IPO potential.
Europe's growing importance is evident in the fund's capital allocation across vintages. The region's share of capital deployed has expanded significantly from 11% in Fund I to 25% by Fund IV, demonstrating that European opportunity sourcing and deal quality have become core to Endeavor Catalyst's investment thesis. The fund's focus areas in Europe span fintech, e-commerce, MedTech, HealthTech, B2B services, and artificial intelligence.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.